Earnings Release
MicroVision Announces First Quarter 2018 Results
REDMOND, Wash., May 09, 2018 (GLOBE NEWSWIRE) -- MicroVision, Inc. (NASDAQ:MVIS), a leader in innovative ultra-miniature projection display and sensing technology, today announced results for the quarter ended March 31, 2018.
Revenue for the first quarter of 2018 was $2.2 million, compared to $0.6 million for the first quarter of 2017. MicroVision's net loss for the first quarter of 2018 was $7.1 million, or $0.09 per share, compared to a net loss of $5.9 million, or $0.09 per share for the first quarter of 2017.
The company has implemented Revenue Standard ASC 606 for the year beginning January 1, 2018. The Company transitioned to the new standard using the full retrospective approach, and per the standard, historical periods have been adjusted as if the new standard was in place for historical periods.
“I am very pleased with the progress we have made over the last several months. Earlier this week we signed a new $10 million worldwide exclusive license agreement with a leading global technology company for the manufacture and distribution of display-only products, one of our five key vertical markets. This new agreement provides validation of our product roadmap and our revised Go-To-Market strategy. We also continued to make significant progress on our previously announced $24 million contract with a Tier 1 technology company,” said Perry Mulligan, MicroVision’s Chief Executive Officer.
“We also have achieved significant milestones in elements of our core technology, including a new time-of-flight ASIC and a next generation, high resolution MEMS scanner, both necessary to enable our goal of being ready for mass production with several of our new products in early 2019. We are currently working to complete the next generation of development kits that will support our Interactive Display and Sensing products,” Mulligan added.
Financial Results Conference Call
The company will host a conference call today to discuss its first quarter 2018 results and current business operations at 5:00 p.m. ET/2:00 p.m. PT. Interested parties can listen to the company's conference call by accessing the Investor Relations’ section of MicroVision’s web site on the Investor Events Calendar page or dialing 1-877-883-0383 (for U.S. participants) or 1-412-902-6506 (for international participants) ten minutes prior to the start of the call using pass code number 9474035. A replay webcast of the call will also be available from the Investor Relations’ section of MicroVision’s web site on the Investor Events Calendar page.
About MicroVision
MicroVision is the creator of PicoP® scanning technology, and ultra-miniature laser projection and sensing solutions. MicroVision’s patented technology is a single platform that can enable projected displays, image capture and interaction for a wide array of future-ready products in this rapidly evolving, always-on world. Extensive research has led MicroVision to become an independently recognized leader in the development of intellectual property. MicroVision’s IP portfolio has been recognized by the Patent Board as a top 50 IP portfolio among global industrial companies and has been included in the Ocean Tomo 300 Patent Index. The company is based in Redmond, Washington.
For more information, visit the company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc or follow MicroVision on Twitter at @MicroVision.
MicroVision and PicoP are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.
Forward-Looking Statements
Certain statements contained in this release, including those relating to providing solutions, benefits under license agreements, progress on development contracts, potential customer agreements, milestones, potential demand for MicroVision technology and products, product roadmaps, Go-To-Market strategy, potential products and applications, features of MicroVision technology, and those containing words such as “validation,” “enable” and “goal” are forward-looking statements that involve risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: our ability to raise additional capital when needed; products incorporating our PicoP® display technology may not achieve market acceptance, commercial partners may not perform under agreements as anticipated, we may be unsuccessful in identifying parties interested in paying any amounts or amounts we deem desirable for the purchase or license of IP assets, our or our customers failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; and other risk factors identified from time to time in the company's SEC reports, including the company's Annual Report on Form 10-K filed with the SEC. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
| | | | | |
| MicroVision, Inc. |
| Balance Sheet |
| (In thousands) |
| (Unaudited) |
| | | March 31, | | December 31, |
| | | | 2018 | | | | 2017 | |
| | | | | | | | | |
| Assets | | | | |
| Current Assets | | | | |
| Cash and cash equivalents | | $ | 7,228 | | | $ | 16,966 | |
| Accounts receivable, net | | | 2,502 | | | | 15 | |
| Costs and estimated earnings in excess of | | | | |
| billings on uncompleted contracts | | | 258 | | | | 680 | |
| Inventory | | | 4,519 | | | | 4,541 | |
| Other current assets | | | 1,547 | | | | 1,015 | |
| Total current assets | | | 16,054 | | | | 23,217 | |
| | | | | |
| Property and equipment, net | | | 2,950 | | | | 3,251 | |
| Restricted cash | | | 435 | | | | 435 | |
| Intangible assets, net | | | 573 | | | | 602 | |
| Other assets | | | 2,506 | | | | 2,262 | |
| Total assets | | $ | 22,518 | | | $ | 29,767 | |
| | | | | |
| | | | | |
| Liabilities and Shareholders' Equity | | | | |
| Current Liabilities | | | | |
| Accounts payable | | $ | 1,989 | | | $ | 3,063 | |
| Accrued liabilities | | | 6,607 | | | | 5,864 | |
| Billings on uncompleted contracts | | | | |
| in excess of related costs | | | 4 | | | | 5 | |
| Other current liabilities | | | 10,103 | | | | 10,142 | |
| Total current liabilities | | | 18,703 | | | | 19,074 | |
| | | | | |
| Deferred rent, net of current portion | | | 366 | | | | 302 | |
| Other long-term liabilities | | | 163 | | | | 305 | |
| Total liabilities | | | 19,232 | | | | 19,681 | |
| | | | | | | | | |
| Commitments and contingencies | | | | |
| |
| Shareholders' Equity | | | | |
| Common stock at par value | | | 79 | | | | 79 | |
| Additional paid-in capital | | | 529,205 | | | | 528,873 | |
| Accumulated deficit | | | (525,998 | ) | | | (518,866 | ) |
| Total shareholders' equity | | | 3,286 | | | | 10,086 | |
| Total liabilities and shareholders' equity | | $ | 22,518 | | | $ | 29,767 | |
| | | | | |
| | | | | |
| MicroVision, Inc. |
| Statement of Operations |
| (In thousands, except earnings per share data) |
| (Unaudited) |
| | | | | |
| | | | | |
| | | Three months ended March 31, |
| | | | 2018 | | | | 2017 | |
| | | | | | | | | |
| |
| Royalty revenue | | $ | 11 | | | $ | 97 | |
| Contract revenue | | | 2,177 | | | | 471 | |
| Total revenue | | | 2,188 | | | | 568 | |
| | | | | | | | | |
| Cost of product revenue | | | 238 | | | | 213 | |
| Cost of contract revenue | | | 1,635 | | | | 403 | |
| Total cost of revenue | | | 1,873 | | | | 616 | |
| | | | | | | | | |
| Gross margin | | | 315 | | | | (48 | ) |
| | | | | | | | | |
| | | | | |
| Research and development expense | | | 4,828 | | | | 3,318 | |
| Sales, marketing, general and administrative expense | | | 2,607 | | | | 2,580 | |
| Total operating expenses | | | 7,435 | | | | 5,898 | |
| | | | | | | | | |
| Loss from operations | | | (7,120 | ) | | | (5,946 | ) |
| | | | | |
| Other income (expense), net | | | (12 | ) | | | (3 | ) |
| | | | | |
| Net loss | | $ | (7,132 | ) | | $ | (5,949 | ) |
| | | | | |
| Net loss per share - basic and diluted | | $ | (0.09 | ) | | $ | (0.09 | ) |
| | | | | |
| Weighted-average shares outstanding - basic and diluted | | | 78,610 | | | | 68,113 | |
| | | | | |
Investor Relations Contacts:
Ted Moreau
Darrow Associates, Inc.
608.298.7369
tmoreau@darrowir.com
or
David H. Allen
Darrow Associates, Inc.
408.427.4463
dallen@darrowir.com
Source: Microvision, Inc.
